GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » EV-to-Revenue

Mizuho Medy Co (TSE:4595) EV-to-Revenue : 1.69 (As of Sep. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Mizuho Medy Co's enterprise value is 円18,757 Mil. Mizuho Medy Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was 円11,083 Mil. Therefore, Mizuho Medy Co's EV-to-Revenue for today is 1.69.

The historical rank and industry rank for Mizuho Medy Co's EV-to-Revenue or its related term are showing as below:

TSE:4595' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.63   Med: 2.31   Max: 8.31
Current: 1.69

During the past 10 years, the highest EV-to-Revenue of Mizuho Medy Co was 8.31. The lowest was 0.63. And the median was 2.31.

TSE:4595's EV-to-Revenue is ranked better than
60.93% of 1006 companies
in the Drug Manufacturers industry
Industry Median: 2.26 vs TSE:4595: 1.69

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-21), Mizuho Medy Co's stock price is 円1570.00. Mizuho Medy Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was 円581.80. Therefore, Mizuho Medy Co's PS Ratio for today is 2.70.


Mizuho Medy Co EV-to-Revenue Historical Data

The historical data trend for Mizuho Medy Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co EV-to-Revenue Chart

Mizuho Medy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.24 3.04 1.41 1.54 1.80

Mizuho Medy Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 1.57 1.80 1.95 1.78

Competitive Comparison of Mizuho Medy Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Mizuho Medy Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mizuho Medy Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mizuho Medy Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mizuho Medy Co's EV-to-Revenue falls into.



Mizuho Medy Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Mizuho Medy Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=18756.519/11082.735
=1.69

Mizuho Medy Co's current Enterprise Value is 円18,757 Mil.
Mizuho Medy Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円11,083 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mizuho Medy Co  (TSE:4595) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Mizuho Medy Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1570.00/581.802
=2.70

Mizuho Medy Co's share price for today is 円1570.00.
Mizuho Medy Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円581.80.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mizuho Medy Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mizuho Medy Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mizuho Medy Co Business Description

Traded in Other Exchanges
N/A
Address
4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co Headlines

No Headlines